🇺🇸 Epirubicin (E) in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Epirubicin (E) on 15 September 1999

Marketing authorisation

FDA — authorised 15 September 1999

Application: NDA050778
Marketing authorisation holder: PFIZER INC
Local brand name: ELLENCE
Indication: INJECTABLE — INJECTION
Status: approved

Read official source →

Other Oncology approved in United States

Frequently asked questions

Is Epirubicin (E) approved in United States?

Yes. FDA authorised it on 15 September 1999.

Who is the marketing authorisation holder for Epirubicin (E) in United States?

PFIZER INC holds the US marketing authorisation.